Cambridge diagnostics company Quanterix Corp. today named former Millipore Corp. president and CEO Martin D. Madaus as executive chairman of the board.
Madaus oversaw the $7 billion acquisition of Billerica bioscience research and biopharmaceutical manufacturing company Millipore Corp. by Merck KGaA earlier this year.
SOURCE